Findings may help guide discussions around prognosis and allogeneic stem cell transplantation
Research underscores the importance of access to timely diagnosis and treatment in this patient population.
A Cleveland Clinic model combining clinical staging, genomics and AI predicts survival with 18% greater accuracy — and could help match patients to more effective treatments.
Study serves as ‘cautionary tale’ for physicians tempted to rely on liquid biopsy results alone
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Direct delivery of viral-based vector KB707 to the lungs may boost anti-tumor response and help overcome immune checkpoint inhibitor resistance
Evidence-based recommendations for managing pain, nausea and other treatment reactions
Emerging data and practice changes reduce toxicity burden of treatment
Understanding supports for adolescent and young adult patients
Introducing Prajwal Rajappa, MD, MS, Director of Pediatric Precision Oncology
Reframing cancer survivorship
Advertisement
Advertisement